Our mission is to make human-milk based, individualized nutrition available worldwide to improve neonatal health. We believe the right nutrition is essential to ensure the best possible outcome for each premature baby.
In December 2018, the FDA cleared Miris’ HMA instrument. Now, for the first time, there is a diagnostic method to measure the nutrients in human milk, available for clinical use in the U.S. This is a big step towards fulfilling our mission and we believe it is worth celebrating!
At the launch party we will bring together some of the leading international experts within neonatal care, to a panel to discuss the implications of this important milestone for patients, neonatologists and healthcare development at large. These panelists will be available for a Q&A session following opening remarks.
We hope you will be able to join us this evening!